SMID Life Science Trades that Picked Up MOMENTUM…Update-4…nothing
Update-4 5/23/24...XBI down 3% to $89 handle, rates up =risk off, But S&P hold 5200. NVDA rules nothing else in broad sell-off. Update-3 5/22...XBI is holding the $92 level and several SMID stocks show gains:ADPT, CRNX,CRSP, PACB, TXG. NTRA near 52 wet high of $110. NVAX up 13% to $16.84...
Healthcare and Biotech Investing 101: What you need to know.
Healthcare and Biotech Investing 101: What you need to know. What is your current allocation for healthcare stocks? Large cap stocks that pay dividends are the best positioned for growth plus value. Start with an ETF plus one Fund. If you have been reading our artlcles you already know some of...
SMID Life Science Trades: Trading Window is Open…Update-5
Update-5 SMIDS are running today. Added NVAX to list. ADPT RXRX XBI are movers. UPDATE-4...AT close...XBI tried to rally back to $90 but closed at $88+. XBI drives SMID biotechs and as you can see it's a red screen day if you are tracking our spec trading list below. BUT the bull market is...
Healthcare Markets Weekly Summary: SMID Biotechs Lagging…Update-3…SMID Biotech Rally Underway
MAY 1..3:00P EDT...XBI up over 5 %, Spec biotech rally! Details later. April 30 ...Sell off at close -FED jitters plus yieldsup not a good combo. Labor costs rise,US consumer sentiment drops ,worst month since 9/22. NAZ and Russell down over 2%, S&P down 1.57%. IS it time for Healthcare...
How Did Biotech and Healthcare Stocks Perform During This 2 Day Trading Rally?…Update-2 earnings deliver!
Update-2 4/26..ABBVIe (ABV) beats on sales and earnings but Humira revenue concerns linger stock down 4+%. SMID caps up: CRMD,CYRX, GERN,SUPN, TXG etc....XBI up 1.5% after dipping to $81 . Update-1 4/25...MRK up over 3% on confirmed guidance Revs at $63-64B,EPS $8.53-8.65, Junuvia drug on...